In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alliance acquires Molecular Biosystems for $11.55mm

Executive Summary

Under terms of an $11.55mm deal, ultrasound contrast agent developer Molecular Biosystems Inc. will become a wholly owned subsidiary of Alliance Pharmaceutical (acute care therapeutics and diagnostics). Alliance acquires all outstanding MBI stock at an exchange ration of 0.04, for a total of 770k Alliance common shares.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies